Falsely elevated parathyroid hormone in a patient with osteoporosis: a case report and review
- 28 December 2023
- journal article
- case report
- Published by Springer Nature in Osteoporosis International
- Vol. 35 (4) , 737-740
Abstract
Background Parathyroid hormone (PTH) measurements can be falsely elevated due to the hormone binding to other molecules (macro-PTH) or immunoassay interference with heterophile, human anti-animal or other antibodies. This is rare but could lead to incorrect diagnosis, unnecessary investigations or avoidance of teriparatide treatment. We report a case of falsely high PTH levels due to assay interference and review the literature on cases of spuriously elevated PTH. Case report An 87-year-old woman attending our bone health clinic with osteoporosis had persistently elevated PTH (383–784 pg/ml) using the Roche Cobas e801 immunoassay despite having normal serum calcium, phosphate, 25 hydroxyvitamin D (> 50 nmol/l) and eGFR (> 60 ml/min). To rule out falsely elevated PTH, a polyethylene glycol precipitation (PEG) test was performed which recovered less than 10% of the hormone resulting in a normal level. PTH was also tested on a different assay (Atellica Siemens) that identified a result of 27 pg/ml. The findings were consistent with immunoassay interference likely due to heterophile antibodies giving rise to a spuriously high PTH. Discussion The presence of unexpectedly high PTH levels should alert physicians to the possibility of false results due to assay interference or macro-PTH. This highlights the importance of clinically correlating results and of good communication with the testing laboratory. Summary Here, we present the case of an 87-year-old woman with spuriously elevated PTH levels due to immunoassay interference likely mediated by heterophile antibodies. The presence of unexpectedly high PTH levels should prompt consideration of the possibility of false results due to assay interference or macro-PTH.Keywords
This publication has 19 references indexed in Scilit:
- Normocalcemia but still elevated parathyroid hormone levels after parathyroidectomyClinical Case Reports, 2018
- Asymptomatic elevated PTH level due to immunoassay interference resulting from Macro-PTH: a case reportEndocrine Abstracts, 2016
- A Case With Immunoassay Interferences in the Measurement of Multiple HormonesThe Journal of Clinical Endocrinology & Metabolism, 2015
- Extremely high parathyroid hormone concentrations associated with pityriasis rubra pilaris and monoclonal gammopathy of unknown significance: A clinical dilemmaBone, 2012
- Analytical error and interference in immunoassay: minimizing riskAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2011
- Falsely Elevated Plasma Parathyroid Hormone Level Mimicking Tertiary HyperparathyroidismEndocrine Practice, 2011
- Human Anti-Mouse Antibodies Interferences in Elecsys PTH Assay After OKT3 TreatmentTransplantation, 2009
- False positive PTH results: An easy strategy to test and detect analytical interferences in routine practiceClinica Chimica Acta, 2008
- Spontaneously occurring anti-PTH autoantibodies must be considered in the differential diagnosis of patients with elevated serum PTH levels1Journal of Endocrinological Investigation, 1999
- Falsely Elevated Serum Parathyroid Hormone Levels due to Immunoglobulin G in a Patient with Idiopathic Hypoparathyroidism*The Journal of Clinical Endocrinology & Metabolism, 1991